MYP_115103
GPLPLR (MT1-MMP-targeting peptide)
Anticancer
Anticancer
▸
Tumor Homing Peptide
Delivery / Targeting
▸
Drug delivery vehicle
Standard
6 amino acids
C30H53N9O7
Standard
GPLPLR
651.80 Da
9.75
0.76
0.56
0.1267
-0.08
0.44
0.05
72.53
130.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
253.14
-1.18
8.0
8.0
17.0
46.0
2.0
5.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0235137
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
MT1-MMP targeting
Tumor homing peptide
Drug delivery vehicle
Anti-angiogenic
Anticancer
Membrane type-1 matrix metalloproteinase (MT1-MMP); human umbilical vein endothelial cells (HUVECs); Colon 26 NL-17 tumor vasculature
>4 fold
In vivo tumor accumulation
RECORD: Rec_0341631
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
-
-
Bio-Activity Profile
MT1-MMP targeting
Tumor homing peptide
Drug delivery vehicle
Anti-angiogenic
Anticancer
Drug Delivery Vehicle
Tumor Homing Peptide
Membrane type-1 matrix metalloproteinase (MT1-MMP); human umbilical vein endothelial cells (HUVECs); Colon 26 NL-17 tumor vasculature
>4 fold
In vivo tumor accumulation